After some less than desirable dermatology results we need to remember what drove this stock last year and our gram positive infection treatment is very much still alive and kicking.
Work led by Dr Mark Blaskovich at The University of Queensland's Institute for Molecular Bioscience's Centre for Superbug Solutions, in collaboration with Botanix Pharmaceuticals Ltd, an early stage drug discovery company investigating topical uses of synthetic cannabidiol for a range of skin conditions, found that Cannabidiol was remarkably effective at killing a wide range of Gram-positive bacteria, including bacteria that have become resistant to other antibiotics, and did not lose effectiveness after extended treatment."Given cannabidiol's documented anti-inflammatory effects, existing safety data in humans, and potential for varied delivery routes, it is a promising new antibiotic worth further investigation," said Dr. Blaskovich. "The combination of inherent antimicrobial activity and potential to reduce damage caused by the inflammatory response to infections is particularly attractive."Importantly, the drug retained its activity against bacteria that have become highly resistant to other common antibiotics. Under extended exposure conditions that lead to resistance against vancomycin or daptomycin, Cannabidiol did not lose effectiveness. Cannabidiol was also effective at disrupting biofilms, a physical form of bacteria growth that leads to difficult-to-treat infections.After some less than desirable phase 2 in regards to dermatology, we need to remember what really made this stock take off last year and it won’t be too long before we get more news on this:
- Forums
- ASX - By Stock
- BOT
- Reminder Why BOT’s Still a Good Thing
Reminder Why BOT’s Still a Good Thing
-
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $671.1M |
Open | High | Low | Value | Volume |
38.0¢ | 38.0¢ | 37.0¢ | $1.949M | 5.207M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 163455 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 33207 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 130837 | 0.370 |
10 | 99517 | 0.365 |
16 | 271384 | 0.360 |
7 | 220353 | 0.355 |
26 | 1051912 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 44778 | 1 |
0.385 | 245000 | 3 |
0.390 | 10960 | 1 |
0.395 | 123443 | 3 |
0.400 | 179748 | 4 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |